Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Clinical benefits of p53 gene therapy

Sep. 27, 1996

Antisense compound displays activity in animal models of human cancer

Sep. 27, 1996

Clinical trial of gene therapy for malignant brain tumors

Sep. 27, 1996

ET-743 product overview and development update

Sep. 27, 1996

Japanese researchers report new antiangiogenic compound

Sep. 27, 1996

Antitumor lipid peroxidation inhibitor from Kirin Brewery

Sep. 27, 1996

Mitsubishi reports isolation of PI 3-kinase inhibitors

Sep. 27, 1996

Prostate cancer treatment approved by the FDA

Sep. 27, 1996

First localized treatment for fatal brain cancer approved by the FDA

Sep. 27, 1996

Joint venture to develop Biopharmaceutics' orphan anticancer drug

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...